XML 115 R17.htm IDEA: XBRL DOCUMENT v3.24.2
Loss Per Common Share
12 Months Ended
Dec. 31, 2023
Loss Per Common Share  
Loss Per Common Share

11. Loss Per Common Share

 

The Company presents the computation of earnings per share (“EPS”) on a basic basis. Basic EPS is computed by dividing net income or loss by the weighted average number of shares outstanding during the reported period. Diluted EPS is computed similarly to basic EPS, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential additional common shares that were dilutive had been issued. Common shares are excluded from the calculation if they are determined to be anti-dilutive. The following table sets forth the weighted average number of common shares outstanding for each period presented.

 

 

Year ended

December 31,

 

 

Six months ended

December 31,

 

 

Year ended

 June 30,

 

 

 

2023

 

 

2022

 

 

2022

 

Weighted average number of common shares outstanding

 

 

10,145,211

 

 

 

7,003,599

 

 

 

6,637,471

 

Effect of dilutive securities:

 

 

-

 

 

 

 

 

 

 

-

 

Weighted average number of dilutive common shares outstanding

 

 

10,145,211

 

 

 

7,003,599

 

 

 

6,637,471

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted loss per common share:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$(1.27)

 

$(0.58 )

 

$(2.06)

Discontinued operations

 

$0

 

 

$0

 

 

$0

 

Consolidated operations

 

$(1.27)

 

$(0.58 )

 

$(2.06)

   

Approximately 1,120,097 and 7,856,203 shares of the Company's common stock issuable upon the exercise of stock options and warrants, respectively, were excluded from the calculation because the effect would be anti-dilutive due to the loss for the year ended December 31, 2023.

 

Approximately 28,645 and 18,481 shares of the Company's common stock issuable upon the exercise of stock options and warrants, respectively, were excluded from the calculation because the effect would be anti-dilutive due to the loss for the six months ended December 31, 2022.

 

Approximately 39,086 and 0 shares of the Company's common stock issuable upon the exercise of stock options and warrants, respectively, were excluded from the calculation because the effect would be anti-dilutive due to the loss for the fiscal year ended June 30, 2022.